Publications

• 1. Gao L
  2. Slack M
  3. Barnas JL
  4. McDavid A
  5. Anolik J
  6. Looney RJ
  Correction to: Cell Senescence in Lupus.; Current rheumatology reports; Vol 21(7). 2019 May 23.
• 1. Gao L
  2. Slack M
  3. McDavid A
  4. Anolik J
  5. Looney RJ
  Cell Senescence in Lupus.; Current rheumatology reports; Vol 21(2). 2019 Jan 14.
• 1. Gao L
  2. Bird AK
  3. Meednu N
  4. Dauenhauer K
  5. Liesveld J
  6. Anolik J
  7. Looney RJ
  Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop.; Arthritis & rheumatology (Hoboken, N.J.); Vol 69(8). 2017 Aug.
• 1. Martina C
  2. Looney RJ
  3. Marcus C
  4. Allen M
  5. Stahlhut R
  Prevalence of allergic disease in Old Order Mennonites in New York.; Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology; Vol 117(5). 2016 Jan.
• 1. Adlowitz DG
  2. Barnard J
  3. Biear JN
  4. Cistrone C
  5. Owen T
  6. Wang W
  7. Palanichamy A
  8. Ezealah E
  9. Campbell D
  10. Wei C
  11. Looney RJ
  12. Sanz I
  13. Anolik JH
  Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response.; PloS one; Vol 10(6). 2015.
• 1. Stohl W
  2. Merrill JT
  3. Looney RJ
  4. Buyon J
  5. Wallace DJ
  6. Weisman MH
  7. Ginzler EM
  8. Cooke B
  9. Holloway D
  10. Kaliyaperumal A
  11. Kuchimanchi KR
  12. Cheah TC
  13. Rasmussen E
  14. Ferbas J
  15. Belouski SS
  16. Tsuji W
  17. Zack DJ
  Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials.; Arthritis research & therapy; Vol 17. 2015.
• 1. Rovin BH
  2. Furie R
  3. Latinis K
  4. Looney RJ
  5. Fervenza FC
  6. Sanchez-Guerrero J
  7. Maciuca R
  8. Zhang D
  9. Garg JP
  10. Brunetta P
  11. Appel G
  Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.; Arthritis and rheumatism; Vol 64(4). 2012 Apr.
• 1. Ichikawa HT
  2. Conley T
  3. Muchamuel T
  4. Jiang J
  5. Lee S
  6. Owen T
  7. Barnard J
  8. Nevarez S
  9. Goldman BI
  10. Kirk CJ
  11. Looney RJ
  12. Anolik JH
  Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells.; Arthritis and rheumatism; Vol 64(2). 2012 Feb.
• 1. Kobie JJ
  2. Zheng B
  3. Bryk P
  4. Barnes M
  5. Ritchlin CT
  6. Tabechian DA
  7. Anandarajah AP
  8. Looney RJ
  9. Thiele RG
  10. Anolik JH
  11. Coca A
  12. Wei C
  13. Rosenberg AF
  14. Feng C
  15. Treanor JJ
  16. Lee FE
  17. Sanz I
  Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.; Arthritis research & therapy; Vol 13(6). 2011.
• 1. Qi Y
  2. Operario DJ
  3. Oberholzer CM
  4. Kobie JJ
  5. Looney RJ
  6. Georas SN
  7. Mosmann TR
  Human basophils express amphiregulin in response to T cell-derived IL-3.; The Journal of allergy and clinical immunology; Vol 126(6). 2010 Dec.
• 1. Marston B
  2. Looney RJ
  Connective tissue diseases: Translating the effects of BAFF in SLE.; Nature reviews. Rheumatology; Vol 6(9). 2010 Sep.
• 1. Looney RJ
  B cell-targeted therapies for systemic lupus erythematosus: an update on clinical trial data.; Drugs; Vol 70(5). 2010 Mar 26.
• 1. Looney RJ
  2. Anolik J
  3. Sanz I
  A perspective on B-cell-targeting therapy for SLE.; Modern rheumatology / the Japan Rheumatism Association; Vol 20(1). 2010 Feb.
• 1. Kwon JB
  2. Kleiner A
  3. Ishida K
  4. Godown J
  5. Ciafaloni E
  6. Looney RJ
  Hydroxychloroquine-induced myopathy.; Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases; Vol 16(1). 2010 Jan.
• 1. Bingham CO
  2. Looney RJ
  3. Deodhar A
  4. Halsey N
  5. Greenwald M
  6. Codding C
  7. Trzaskoma B
  8. Martin F
  9. Agarwal S
  10. Kelman A
  Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.; Arthritis and rheumatism; Vol 62(1). 2010 Jan.
• 1. Anolik JH
  2. Looney RJ
  3. Lund FE
  4. Randall TD
  5. Sanz I
  Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets.; Immunologic research; Vol 45(2-3). 2009 Dec.
• 1. Coca A
  2. Bundy KW
  3. Marston B
  4. Huggins J
  5. Looney RJ
  Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin.; Clinical immunology (Orlando, Fla.); Vol 132(1). 2009 Jul.
• 1. Palanichamy A
  2. Barnard J
  3. Zheng B
  4. Owen T
  5. Quach T
  6. Wei C
  7. Looney RJ
  8. Sanz I
  9. Anolik JH
  Novel human transitional B cell populations revealed by B cell depletion therapy.; Journal of immunology (Baltimore, Md. : 1950); Vol 182(10). 2009 May 15.
• 1. Brown RJ
  2. Rother KI
  3. Artman H
  4. Mercurio MG
  5. Wang R
  6. Looney RJ
  7. Cowen EW
  Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae.; Archives of dermatology; Vol 145(1). 2009 Jan.
• 1. Looney RJ
  Update on the use of rituximab for intractable rheumatoid arthritis.; Open access rheumatology : research and reviews; Vol 1. 2009.
• 1. Albert D
  2. Dunham J
  3. Khan S
  4. Stansberry J
  5. Kolasinski S
  6. Tsai D
  7. Pullman-Mooar S
  8. Barnack F
  9. Striebich C
  10. Looney RJ
  11. Prak ET
  12. Kimberly R
  13. Zhang Y
  14. Eisenberg R
  Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.; Annals of the rheumatic diseases; Vol 67(12). 2008 Dec.
• 1. Kleiner A
  2. Looney RJ
  Is rituximab suitable for use as a first-line biologic therapy for RA?; Nature clinical practice. Rheumatology; Vol 4(11). 2008 Nov.
• 1. Mehta LR
  2. Samuelsson MK
  3. Kleiner AK
  4. Goodman AD
  5. Anolik JH
  6. Looney RJ
  7. Schwid SR
  Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome.; Multiple sclerosis (Houndmills, Basingstoke, England); Vol 14(3). 2008 Apr.
• 1. Nicholas MW
  2. Dooley MA
  3. Hogan SL
  4. Anolik J
  5. Looney J
  6. Sanz I
  7. Clarke SH
  A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE.; Clinical immunology (Orlando, Fla.); Vol 126(2). 2008 Feb.
• 1. Looney RJ
  2. Srinivasan R
  3. Calabrese LH
  The effects of rituximab on immunocompetency in patients with autoimmune disease.; Arthritis and rheumatism; Vol 58(1). 2008 Jan.
• 1. Brown RJ
  2. Rother KI
  3. Mercurio MG
  4. Wang R
  5. Looney RJ
  6. Cowen EW
  Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae; Archives of Dermatology. 2008 Jan 01.
• 1. Kleiner A
  2. Looney RJ
  Commentary: rituximab as first line therapy for rheumatoid arthritis; Nature Clinical Practice in Rheumatology. 2008 Jan 01.
• 1. Reddy MB
  2. Looney RJ
  3. Utell MJ
  4. Plotzke KP
  5. Andersen ME
  Modeling of human dermal absorption of octamethylcyclotetrasiloxane (D(4)) and decamethylcyclopentasiloxane (D(5)).; Toxicological sciences : an official journal of the Society of Toxicology; Vol 99(2). 2007 Oct.
• 1. Ravikumar R
  2. Anolik J
  3. Looney RJ
  Vaccine responses in patients with rheumatoid arthritis.; Current rheumatology reports; Vol 9(5). 2007 Oct.
• 1. Anolik JH
  2. Barnard J
  3. Owen T
  4. Zheng B
  5. Kemshetti S
  6. Looney RJ
  7. Sanz I
  Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy.; Arthritis and rheumatism; Vol 56(9). 2007 Sep.
• 1. Looney RJ
  2. Stohl W
  New and promising treatments for rheumatoid arthritis.; American journal of orthopedics (Belle Mead, N.J.); Vol 36(7 Suppl). 2007 Jul.
• 1. Looney RJ
  2. Diamond B
  3. Holers VM
  4. Levesque MC
  5. Moreland L
  6. Nahm MH
  7. St Clair EW
  Guidelines for assessing immunocompetency in clinical trials for autoimmune diseases.; Clinical immunology (Orlando, Fla.); Vol 123(3). 2007 Jun.
• 1. Looney RJ
  Will targeting B cells be the answer for Sjögren's syndrome?; Arthritis and rheumatism; Vol 56(5). 2007 May.
• 1. Sanz I
  2. Anolik JH
  3. Looney RJ
  B cell depletion therapy in autoimmune diseases.; Frontiers in bioscience : a journal and virtual library; Vol 12. 2007.
• 1. Anolik JH
  2. Barnard J
  3. Owen T
  4. Zheng B
  5. Kemshetti S
  6. Looney RJ
  7. Sanz I
  Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy; Arthritis & Rheumatism; Vol 56(9), pp. 3004-3056. 2007 Jan 01.
• 1. Ravikumar R
  2. Anolik J
  3. Looney R
  Vaccine responses in patients with rheumatoid arthritis; Current Rheumatology Reports; Vol 9(5), pp. 407-415. 2007 Jan 01.
• 1. Stohl W
  2. Looney RJ
  B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks?; Clinical immunology (Orlando, Fla.); Vol 121(1). 2006 Oct.
• 1. Schwarz EM
  2. Looney RJ
  3. Drissi MH
  4. O'Keefe RJ
  5. Boyce BF
  6. Xing L
  7. Ritchlin CT
  Autoimmunity and bone.; Annals of the New York Academy of Sciences; Vol 1068. 2006 Apr.
• 1. Looney RJ
  2. Anolik J
  3. Sanz I
  New therapies for systemic lupus erythematosus: cellular targets.; Rheumatic diseases clinics of North America; Vol 32(1). 2006 Feb.
• 1. Looney RJ
  2. Schwarz EM
  3. Boyd A
  4. O'Keefe RJ
  Periprosthetic osteolysis: an immunologist's update.; Current opinion in rheumatology; Vol 18(1). 2006 Jan.
• 1. Looney RJ
  2. Huggins J
  Use of intravenous immunoglobulin G (IVIG).; Best practice & research. Clinical haematology; Vol 19(1). 2006.
• 1. Looney RJ
  B cell-targeted therapy for rheumatoid arthritis: an update on the evidence.; Drugs; Vol 66(5). 2006.
• 1. Schwarz EM
  2. Looney RJ
  3. Drissi H
  4. O'Keefe RJ
  5. Boyce BF
  6. Zing L
  7. Ritchlin CT
  Autoimmunity and bone; Annals of the New York Academy of Science; Vol 1068, pp. 275-283. 2006 Jan 01.
• 1. Looney RJ
  B cell-targeted therapy for rheumatoid arthritis: an update on the evidence; Drugs; Vol 66, pp. 325-339. 2006 Jan 01.
• 1. Eisenberg R
  2. Looney RJ
  The therapeutic potential of anti-CD20 "what do B-cells do?".; Clinical immunology (Orlando, Fla.); Vol 117(3). 2005 Dec.
• 1. Looney RJ
  Discovering that B cells are important in rheumatoid arthritis.; The Journal of rheumatology; Vol 32(11). 2005 Nov.
• 1. Looney RJ
  2. Anolik J
  3. Sanz I
  Treatment of SLE with anti-CD20 monoclonal antibody.; Current directions in autoimmunity; Vol 8. 2005.
• 1. Schwarz EM
  2. O'Keefe RJ
  3. Zing L
  4. Looney RJ
  5. Ritchlin CT
  Receptor activator of nuclear kappa ligand and osteoprotegerin: where are we now and what about future treatment uses?; Current Opinion in Orthopedics; Vol 16, pp. 370-375. 2005 Jan 01.
• 1. Anolik JH
  2. Barnard J
  3. Cappione A
  4. Pugh-Bernard AE
  5. Felgar RE
  6. Looney RJ
  7. Sanz I
  Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus.; Arthritis and rheumatism; Vol 50(11). 2004 Nov.
• 1. Huggins JL
  2. Looney RJ
  Allergen immunotherapy.; American family physician; Vol 70(4). 2004 Aug 15.

View all publications